1. Home
  2. FBIOP vs TFINP Comparison

FBIOP vs TFINP Comparison

Compare FBIOP & TFINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
    SELLHOLDBUYas of a day ago
  • TFINP
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • FBIOP N/A
  • TFINP N/A
  • Country
  • FBIOP United States
  • TFINP United States
  • Employees
  • FBIOP 186
  • TFINP 1553
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • TFINP Major Banks
  • Sector
  • FBIOP Health Care
  • TFINP Finance
  • Exchange
  • FBIOP Nasdaq
  • TFINP Nasdaq
  • Market Cap
  • FBIOP N/A
  • TFINP N/A
  • IPO Year
  • FBIOP N/A
  • TFINP N/A
  • Fundamental
  • Price
  • FBIOP $5.73
  • TFINP $21.33
  • Analyst Decision
  • FBIOP
  • TFINP
  • Analyst Count
  • FBIOP 0
  • TFINP 0
  • Target Price
  • FBIOP N/A
  • TFINP N/A
  • AVG Volume (30 Days)
  • FBIOP N/A
  • TFINP N/A
  • Earning Date
  • FBIOP N/A
  • TFINP N/A
  • Dividend Yield
  • FBIOP N/A
  • TFINP N/A
  • EPS Growth
  • FBIOP N/A
  • TFINP N/A
  • EPS
  • FBIOP N/A
  • TFINP N/A
  • Revenue
  • FBIOP N/A
  • TFINP N/A
  • Revenue This Year
  • FBIOP N/A
  • TFINP N/A
  • Revenue Next Year
  • FBIOP N/A
  • TFINP N/A
  • P/E Ratio
  • FBIOP N/A
  • TFINP N/A
  • Revenue Growth
  • FBIOP N/A
  • TFINP N/A
  • 52 Week Low
  • FBIOP N/A
  • TFINP N/A
  • 52 Week High
  • FBIOP N/A
  • TFINP N/A
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 35.45
  • TFINP 32.46
  • Support Level
  • FBIOP $5.50
  • TFINP $21.65
  • Resistance Level
  • FBIOP $6.74
  • TFINP $21.97
  • Average True Range (ATR)
  • FBIOP 0.27
  • TFINP 0.27
  • MACD
  • FBIOP -0.09
  • TFINP -0.04
  • Stochastic Oscillator
  • FBIOP 31.99
  • TFINP 49.01

Stock Price Comparison Chart: FBIOP vs TFINP

FBIOP
TFINP
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April024681012141618202224262830FBIOP VS TFINP

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About TFINP Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use